IISc-incubated Mynvax 
Dealstreet

Argus, IndusLaw acts on Mynvax $4.2 million fund raise from Accel and others

LetsVenture and a few early-stage angel investors also participated in this round.

Bar & Bench

Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) has raised $4.2 million (₹31 crores) in its Series A funding round led by Accel.

Argus Partners advised Mynvax and the team was led by Partner Vinod Joseph along with Associate Anurag Prasad.

IndusLaw acted for Accel and the team was led by Partner Anindya Ghosh. along with Principal Associate Ashwin Krishnan and Associate Manisha Nayak.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Justice M Sundar appointed Chief Justice of Manipur High Court

Private law colleges: Five-star promises, one-star delivery

Courting controversy: De-liberation of deliberation

Inside the Ivory Tower

Supreme Court issues slew of directions to protect homebuyers and strengthen NCLT, NCLAT and RERAs

SCROLL FOR NEXT